Mood & Emotional WellnessNot Depressed. Just Not Yourself.

You are still showing up. Still functioning. By most external measures, things are fine. But something has shifted — and you know it. You cry at things that wouldn't have touched you before. You snap at people you love, then wonder where that came from. Or you feel nothing in particular, a quiet flatness where engagement and motivation used to be. You've searched for a reason. The explanation that doesn't usually come up first — but often matters most — is hormonal.

The Emotional Experience That Doesn't Have a Name

There is a specific kind of emotional change that does not fit neatly into clinical categories. It is not depression in the way depression is usually described. It does not match the diagnostic criteria for an anxiety disorder. And yet something is clearly different.

You might recognize it as crying at things that never used to affect you — a commercial, a song, someone else's minor frustration. Or snapping at your partner or children over things that wouldn't have registered before. Or feeling flat in situations that used to feel meaningful — a promotion, a vacation, a conversation with someone you care about. A background hum of irritability with no clear source. Feeling like a stranger to your own emotional responses.

Women in perimenopause describe it as "feeling like I don't recognize myself." Men describe it differently: "I've just stopped caring about things I used to care about." Both descriptions are pointing at the same underlying reality.

This is not a character flaw. It is not simply stress, though stress makes it worse. For many adults in their late 30s through 50s, this experience has a measurable hormonal correlate — and understanding that correlate is the first step toward addressing it clearly.

How Hormones Shape Your Emotional Experience

The connection between hormones and mood is not metaphorical. It is mechanistic. Four hormones in particular function as direct regulators of the neurochemical systems that govern emotional experience.

Estrogen and neurotransmitter signaling

Estrogen supports the synthesis, release, and receptor sensitivity of serotonin, dopamine, and norepinephrine — three neurotransmitters that regulate mood stability, motivation, and the ability to experience reward. When estrogen levels are stable, this system tends to function predictably. When estrogen fluctuates erratically, as it does during perimenopause, the downstream effects on mood can be significant and unpredictable. This is why emotional symptoms tied to hormonal imbalance don't follow a neat pattern — the hormonal input isn't neat.

Progesterone and the GABA system

Progesterone is metabolized in the brain into allopregnanolone, a potent modulator of GABA-A receptors. GABA is the brain's primary calming neurotransmitter — the signal that turns down reactivity, supports sleep, and creates a baseline sense of ease. When progesterone declines, GABA tone drops with it. The result is a nervous system that is measurably harder to calm: increased anxiety, restlessness, sleep fragmentation, and emotional reactivity that feels disproportionate to circumstances.

Testosterone and emotional drive

Testosterone is present in both men and women and supports motivation, sustained engagement, and emotional resilience. Low testosterone does not typically produce sadness in the way low estrogen can. It produces absence — reduced drive, diminished interest, a flattening of emotional range. This is the hormone most commonly behind the experience of "I just don't care anymore."

Cortisol and the override effect

Chronic stress elevates cortisol, which suppresses sex hormone production and disrupts the delicate signaling balance that the hormones above depend on. A patient managing chronic high cortisol may have low energy and mood disruption even when their sex hormone levels appear adequate. Cortisol is the override signal — when it stays elevated too long, everything else pays the price.

Perimenopause, Menopause, and Emotional Volatility in Women

Most conversations about menopause focus on hot flashes. But the emotional symptoms — and the hormonal shifts that cause them — often begin years earlier.

Progesterone typically begins declining in the late 30s, before estrogen shows significant change. This early progesterone loss is the primary driver of the anxiety, sleep disruption, and emotional reactivity that many women experience in their late 30s and early 40s — before anyone has mentioned the word perimenopause to them. Many women in this phase have been told it is anxiety. Some have been prescribed antidepressants. The underlying hormonal picture is often never evaluated.

As perimenopause progresses, estrogen becomes volatile. Perimenopause is not simply a period of low estrogen — estrogen can spike and crash within the same cycle, or cycle to cycle. That unpredictability, not a consistent deficiency, is what produces the mood instability women often find most disorienting. One week feels manageable. The next does not. The emotional terrain shifts without warning.

This experience is not a personality change. It is a neurochemical change driven by measurable hormonal shifts. The distinction matters — not just for how you understand what is happening, but for how it can be addressed. Hormone optimization for women at Body Balance Medical begins with an accurate picture of where those levels actually are.

Emotional Flatness in Men: The Testosterone Connection

Testosterone in men declines gradually from the mid-30s onward — roughly 1% per year on average, though the rate varies considerably by individual. The decline is slow enough that it often goes unrecognized. There is no clear before and after. There is just a quiet drift: less motivation, less engagement, less interest in the things that used to generate it.

Men in this situation rarely describe feeling depressed. They describe feeling flat. The work gets done, the obligations are met — but the sense of meaning or drive behind them has thinned. Irritability is common, as are sleep disruption and declining mental focus. Because the onset is gradual and the symptoms are non-specific, the usual explanation is stress, aging, or "just how things are now."

For men whose testosterone decline is clinically significant, testosterone replacement therapy is an established option. A common concern is cardiovascular safety. The TRAVERSE trial — the largest randomized controlled trial of testosterone replacement in men with documented hypogonadism, overseen by the Cleveland Clinic — found that testosterone therapy did not result in a higher incidence of major adverse cardiac events compared to placebo. Cleveland Clinic's summary of the TRAVERSE findings is worth reading in full. The study also noted elevated rates of atrial fibrillation, acute kidney injury, and pulmonary embolism in the testosterone group — which is why careful evaluation, monitored dosing, and a provider who takes a thorough medical history are not optional steps.

When to Seek Mental Health Support vs. Hormonal Evaluation

These two paths are not mutually exclusive — but they are different, and the starting point matters.

Body Balance Medical does not require patients to choose between these paths. When it is appropriate, Mia LoPreiato, NP, collaborates with a patient's existing medical providers. The goal is to ensure that all contributing factors — including hormonal ones — are accounted for, not to replace care that belongs elsewhere.

How Body Balance Medical Evaluates Mood and Emotional Concerns

Mia LoPreiato, NP — Biote-Certified, Hormone Optimization and Longevity Nurse Practitioner — conducts all hormone optimization evaluations at Body Balance Medical.

The evaluation process is thorough before it is directive. Mia reviews detailed symptom history and timing, assesses the full hormonal picture through lab work — including estrogen, progesterone, testosterone, and thyroid markers, with cortisol evaluated where clinically appropriate — and incorporates InBody scan data to provide metabolic context. A patient's body composition, muscle mass, and metabolic rate all interact with hormonal function in ways that matter for this kind of evaluation.

The aim is to understand what is actually measurable before discussing any options. Mia presents findings and explains what they mean in plain language. She outlines what options exist, what each involves, and what individual responses typically look like — including the fact that results vary and are not guaranteed. BBM uses Biote-method bioidentical hormone pellet therapy as one delivery method, alongside other approaches depending on what the clinical picture supports.

No two evaluations produce the same outcome because no two patients have identical lab patterns, histories, or goals. The process is collaborative. Findings and options are presented clearly; the decisions belong to you.

Your Provider for Hormonal Mood Evaluation in Las Vegas

Mia LoPreiato, NP

Biote-Certified · Hormone Optimization & Longevity Nurse Practitioner

Mia approaches emotional wellness as a clinical question before it's a treatment question. She evaluates estrogen, progesterone, testosterone, thyroid, and cortisol patterns in the context of a patient's full symptom picture — not as individual data points in isolation. The InBody scan adds metabolic context. The conversation is collaborative: she presents what she finds, explains what it means, and outlines options with realistic expectations. Hormone optimization is not FDA-approved to treat mood disorders, and results vary. What she offers is an accurate, data-driven picture — and, where it fits, a clinical path that many patients find meaningful. Better Balance, Better You includes how you feel on the inside.

Body Balance Medical is LegitScript Certified, verifying our prescribing and dispensing practices meet applicable laws and standards. All evaluations are in-person at 7975 W Sahara Ave #101, Summerlin, Las Vegas.

Frequently Asked Questions